These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 11479401)

  • 41. Immunoanalytical characteristics of fecal calprotectin.
    Desbène C; Gaillard O; Kapel N
    Ann Biol Clin (Paris); 2016 Dec; 74(6):725-734. PubMed ID: 27848924
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Faecal calprotectin: non-invasive marker of gastrointestinal inflammation in Salmonella infected rats.
    Naughton PJ; Clohessy PA; Grant G; Pusztai A; Golden B
    Biochem Soc Trans; 1996 May; 24(2):308S. PubMed ID: 8736966
    [No Abstract]   [Full Text] [Related]  

  • 43. [Fecal calprotectin in differential diagnosis of irritable bowel syndrome].
    Li XG; Lu YM; Gu F; Yang XL
    Beijing Da Xue Xue Bao Yi Xue Ban; 2006 Jun; 38(3):310-3. PubMed ID: 16778979
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Prediction of disease activity of Crohn's disease through fecal calprotectin evaluated by balloon-assisted endoscopy.
    Iwamoto F; Matsuoka K; Motobayashi M; Takenaka K; Kuno T; Tanaka K; Tsukui Y; Kobayashi S; Yoshida T; Fujii T; Saito E; Yamaguchi T; Nagahori M; Sato T; Ohtsuka K; Enomoto N; Watanabe M
    J Gastroenterol Hepatol; 2018 Dec; 33(12):1984-1989. PubMed ID: 29889986
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Rapid Fecal Calprotectin Test and Symptom Index in Monitoring the Disease Activity in Colonic Inflammatory Bowel Disease.
    Puolanne AM; Kolho KL; Alfthan H; Ristimäki A; Mustonen H; Färkkilä M
    Dig Dis Sci; 2017 Nov; 62(11):3123-3130. PubMed ID: 28948412
    [TBL] [Abstract][Full Text] [Related]  

  • 46. High level of fecal calprotectin at age 2 months as a marker of intestinal inflammation predicts atopic dermatitis and asthma by age 6.
    Orivuori L; Mustonen K; de Goffau MC; Hakala S; Paasela M; Roduit C; Dalphin JC; Genuneit J; Lauener R; Riedler J; Weber J; von Mutius E; Pekkanen J; Harmsen HJM; Vaarala O;
    Clin Exp Allergy; 2015 May; 45(5):928-939. PubMed ID: 25758537
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Validation of Two Calprotectin Rapid Tests in Daily Routine.
    Schulz C; Wex T; Arnim UV; Malfertheiner P
    Clin Lab; 2016 Jul; 62(7):1249-1254. PubMed ID: 28164652
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Relationship between intestinal permeability and calprotectin concentration in gut lavage fluid.
    Berstad A; Arslan G; Folvik G
    Scand J Gastroenterol; 2000 Jan; 35(1):64-9. PubMed ID: 10672837
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Fecal M2-pyruvate kinase (M2-PK): a novel marker of intestinal inflammation.
    Chung-Faye G; Hayee B; Maestranzi S; Donaldson N; Forgacs I; Sherwood R
    Inflamm Bowel Dis; 2007 Nov; 13(11):1374-8. PubMed ID: 17577247
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Newer fecal tests: opportunities for professionals in laboratory medicine.
    Fraser CG; Allison JE; Young GP; Halloran SP
    Clin Chem; 2012 Jun; 58(6):963-5. PubMed ID: 22452971
    [No Abstract]   [Full Text] [Related]  

  • 51. Comparison of three commercial fecal calprotectin ELISA test kits used in patients with Inflammatory Bowel Disease.
    Mirsepasi-Lauridsen HC; Bachmann Holmetoft U; Ingdam Halkjær S; Angeliki Krogfelt K; Munk Petersen A
    Scand J Gastroenterol; 2016; 51(2):211-7. PubMed ID: 26359672
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Fecal calprotectin is a surrogate marker for endoscopic lesions in inflammatory bowel disease.
    D'Haens G; Ferrante M; Vermeire S; Baert F; Noman M; Moortgat L; Geens P; Iwens D; Aerden I; Van Assche G; Van Olmen G; Rutgeerts P
    Inflamm Bowel Dis; 2012 Dec; 18(12):2218-24. PubMed ID: 22344983
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Faecal calprotectin is a useful biomarker for intestinal inflammation].
    Theede K; Kiszka-Kanowitz M; Nordgaard-Lassen I; Nielsen AM
    Ugeskr Laeger; 2014 Sep; 176(37):. PubMed ID: 25294035
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Calprotectin expression and mononuclear phagocyte subpopulations in peripheral blood and bronchoalveolar lavage.
    Striz I; Pokorná-Sochurkova H; Zheng L; Jaresová M; Guzman J; Costabel U
    Sarcoidosis Vasc Diffuse Lung Dis; 2001 Mar; 18(1):57-63. PubMed ID: 11354548
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Fecal calprotectin concentrations in adult dogs with chronic diarrhea.
    Grellet A; Heilmann RM; Lecoindre P; Feugier A; Day MJ; Peeters D; Freiche V; Hernandez J; Grandjean D; Suchodolski JS; Steiner JM
    Am J Vet Res; 2013 May; 74(5):706-11. PubMed ID: 23627383
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Interest of fecal calprotectine dosage in inflammatory bowel diseases, state of the art and perspectives.
    Chaabouni T; Manceau H; Peoc'h K
    Ann Biol Clin (Paris); 2016 Aug; 74(4):385-94. PubMed ID: 27492691
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Practical fecal calprotectin cut-off value for Japanese patients with ulcerative colitis.
    Urushikubo J; Yanai S; Nakamura S; Kawasaki K; Akasaka R; Sato K; Toya Y; Asakura K; Gonai T; Sugai T; Matsumoto T
    World J Gastroenterol; 2018 Oct; 24(38):4384-4392. PubMed ID: 30344422
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Profile of Consecutive Fecal Calprotectin Levels in the Perioperative Period and Its Predictive Capacity for Early Endoscopic Recurrence in Crohn's Disease.
    Liu R; Guo Z; Cao L; Wang Z; Gong J; Li Y; Zhu W
    Dis Colon Rectum; 2019 Mar; 62(3):318-326. PubMed ID: 30451756
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Comparison of Fecal Calprotectin Methods for Predicting Relapse of Pediatric Inflammatory Bowel Disease.
    Kittanakom S; Shajib MS; Garvie K; Turner J; Brooks D; Odeh S; Issenman R; Chetty VT; Macri J; Khan WI
    Can J Gastroenterol Hepatol; 2017; 2017():1450970. PubMed ID: 28491862
    [No Abstract]   [Full Text] [Related]  

  • 60. Accuracy of fecal calprotectin for the prediction of endoscopic activity in patients with inflammatory bowel disease.
    Jusué V; Chaparro M; Gisbert JP
    Dig Liver Dis; 2018 Apr; 50(4):353-359. PubMed ID: 29396129
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.